Abstract |
Vascular endothelial growth factor ( VEGF) is an important regulating molecule of angiogenesis in tumor formation and progression. Cancer cells always secrete VEGF to stimulate angiogenesis that facilitate growth and invasion of the tumor. In this study, we established a VEGF164 overexpressing LL/2 lung cancer cell model and found that the postirradiated VEGF164-modified tumor cells protected the host against the challenge with LL/2 wild-type tumor cells. Histochemical assay showed that there were large areas of tumor necrosis with macrophage infiltration in the mice vaccinated with the VEGF164-modified tumor vaccine. T-cells isolated from the vaccinated mice showed cytotoxicity against the parental tumor cells in a dose-dependent manner. Meanwhile, sera from the mice vaccinated with LL/2-VEGF164 showed higher titers of antibodies against parental tumor cells compared with the nonvaccinated groups. Our results indicated that VEGF164-modified tumor vaccine could modulate host antitumor immune response and hold therapeutic potential for cancer.
|
Authors | Bing Kan, Li Yang, Yan-Jun Wen, Jin-Rong Yang, Ting Niu, Jiong Li, Hong-Xin Deng, Wei Wei, Li-Gong Chen, Quan Zhang, Wei Wang, Yu-Quan Wei |
Journal | Anti-cancer drugs
(Anticancer Drugs)
Vol. 28
Issue 2
Pg. 197-205
(02 2017)
ISSN: 1473-5741 [Electronic] England |
PMID | 27775991
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Cancer Vaccines
- Vascular Endothelial Growth Factor A
- vascular endothelial growth factor A, mouse
|
Topics |
- Animals
- CD4-Positive T-Lymphocytes
(immunology)
- CD8-Positive T-Lymphocytes
(immunology)
- Cancer Vaccines
(genetics, immunology)
- Dose-Response Relationship, Immunologic
- Female
- Immunotherapy, Adoptive
(methods)
- Lung Neoplasms
(genetics, immunology, metabolism, therapy)
- Mice
- Mice, Inbred C57BL
- T-Lymphocytes, Cytotoxic
(immunology)
- Transfection
- Vascular Endothelial Growth Factor A
(administration & dosage, biosynthesis, genetics, immunology)
|